RXO's Q3 10-Q: $3M Net Income, Negative $22M Operating Cash Flow, $175M Merger Break Fee
RXO has more than doubled off its 52-week low of $10.425.
Summary
RXO's Q3 10-Q shows a $3 million quarterly profit on $1.9 billion of revenue, but nine-month operating cash flow turned negative at $22 million used. The filing also details a $175 million merger termination fee and confirms the $30.25 per share C.H. Robinson deal terms.
Key Events · Earnings and Guidance · RXO
-
Q3 Swings to $3M Profit
Revenue rose 31.7% to $1,871 million from $1,421 million, producing operating income of $17 million versus a $7 million loss and net income of $3 million versus a $14 million loss a year ago.
-
Operating Cash Flow Turns Negative
Nine-month operating cash flow was negative $22 million versus positive $44 million in 2025, driven by a $261 million receivables build; capital spending was $42 million.
-
Merger Break Fee Disclosed
New risk factors state RXO would owe a $175 million termination fee under specified circumstances, and that MFN Partners (~19% holder) has agreed to vote its shares in favor of the C.H. Robinson deal.
-
Debt Refinancing Complete
The $400 million 6.375% notes due 2031 were issued February 20, 2026, and the 2027 notes were redeemed at 101.875% of par, producing an $11 million extinguishment loss; $335 million remains available on the $450 million ABL facility.
Analysis · RXO · Energy & Transportation
On paper, the quarter marks a turnaround: RXO swung to $3 million of net income from a $14 million loss a year ago as revenue rose 31.7% to $1.9 billion. The cash flow statement, however, reveals the cost of that growth. Nine-month operating cash flow was negative $22 million versus positive $44 million in 2025, because receivables ballooned by $261 million. With the C.H. Robinson deal pending, the balance sheet matters less than the closing conditions, and the 10-Q adds two facts investors did not have: a $175 million termination fee RXO would owe under specified circumstances, and confirmation that MFN Partners' roughly 19% stake is committed to vote for the deal. The $30.25 per share consideration is unchanged from the October 5 announcement, so the arb spread now hinges on regulatory approval and the shareholder vote, with closing expected in the first half of 2027.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RXO was trading at $27.65 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $10.43 to $29.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.